ExploreInterventionKnowledge level about sexual function during pregnancy and postpartum
Intervention

Knowledge level about sexual function during pregnancy and postpartum

Also known as: Knowledge level about sexual function during pregnancy and postpartum Knowledge level about sexual function during pregnancy and postpartum (observable entity) pregnancy and postpartum period (temporal trajectory of overdose risk)
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
outcomes
populations
studys

Findings (27)

None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9
None
decline

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Size: 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 p CI: 95% CI 1.6-6.1 (3rd trimester); 95% CI 9

Papers (1)